Literature DB >> 4030776

Biosynthesis of platelet activating factor. Substrate specificity of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase in rat spleen microsomes.

T C Lee.   

Abstract

The substrate requirements and specificity of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine (alkyllyso-GPC):acetyl-CoA acetyltransferase were investigated. The following findings were observed. 1) When the ether bond of alkyllyso-GPC is substituted with an ester linkage, the resulting compound, palmitoyllyso-GPC, can serve as a substrate, albeit at a reduced rate (50%). In addition, palmitoyllyso-GPC is a competitive inhibitor in the reaction with respect to concentration dependence of alkyllyso-GPC and a noncompetitive inhibitor when the concentrations of acetyl-CoA are varied. 2) Octadecyllyso-GPC is acetylated at a slightly higher rate than hexadecyllyso-GPC and unsaturated alkyllyso-GPC is a preferable substrate to its saturated counterpart. 3) The homologous series of short chain acyl-CoAs demonstrate an inverse relationship of chain length with the values of their apparent Km and Vmax, e.g. the longer the acyl-CoA chain, the smaller the values of Vmax and apparent Km. 4) The effect of polar head group modification of alkyllyso-GPC on the acetyltransferase activity is related to the degree of methylation of the amine group. The choline base analog gives the highest enzyme activity and the ethanolamine derivative is the least active, while N', N'-dimethylethanolamine and monomethylethanolamine analogs are the substrates with intermediate activities. These results on substrate selectivity of acetyltransferase correlate with the known structural requirements essential for the biological activities elicited by platelet activating factor and thus suggest that the acetyltransferase activating factor and thus suggest that the acetyltransferase may be important in governing the chemical structure of platelet activating factor synthesized in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4030776

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Lipid acetylation reactions and the metabolism of platelet-activating factor.

Authors:  R R Baker
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

2.  Regulation of the biosynthesis of platelet-activating factor in alveolar macrophages.

Authors:  T Sugiura; A Ojima-Uchiyama; Y Masuzawa; M Fujita; Y Nakagawa; K Waku
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Kinetic studies of human and rat neutrophil lysoPAF acetyltransferase using lysoPAF and dansyllysoPAF as substrates.

Authors:  P W Schindler; E Ninio
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  Dietary alpha-linolenate suppresses endotoxin-induced platelet-activating factor production in rat kidney.

Authors:  K Oh-hashi; T Takahashi; A Tanabe; S Watanabe; H Okuyama
Journal:  Lipids       Date:  1999-01       Impact factor: 1.880

5.  Capillary gas chromatography and tandem mass spectrometry of paf-acether and analogs: absence of 1-O-alkyl-2-propionyl-sn-glycero-3-phosphocholine in human polymorphonuclear neutrophils.

Authors:  M J Bossant; R Farinotti; F De Maack; G Mahuzier; J Benveniste; E Ninio
Journal:  Lipids       Date:  1989-02       Impact factor: 1.880

6.  Studies on the selectivity of enzymes involved in platelet-activating factor formation in stimulated cells.

Authors:  H van den Bosch; A Sturk; J W ten Cate; A J Aarsman
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.